Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for practical synthesizing optically active 2 - amido - 8 - butenic acid

A technology of optical activity and synthesis method, which is applied in the practical synthesis field of optically active 2-amino-8-nonenoic acid, can solve the problems of high cost and use price, and achieve the effects of improving synthesis efficiency, reducing cost and reasonable process selection.

Active Publication Date: 2007-12-26
上海药明康德新药开发有限公司
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0016] The technical problem to be solved in the present invention is: develop the synthetic technique of practical optical activity 2-amino-8-nonenoic acid, avoid existing technique to use expensive chiral catalyst or resolution reagent; Shorten the route of existing synthetic technique , increase yield, reduce cost

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for practical synthesizing optically active 2 - amido - 8 - butenic acid
  • Method for practical synthesizing optically active 2 - amido - 8 - butenic acid
  • Method for practical synthesizing optically active 2 - amido - 8 - butenic acid

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Synthesis of (S)-N-tert-butoxycarbonyl-2-amino-8-nonenoic acid

[0025] Step 1: Synthesis of (S)-N-tert-butoxycarbonyl-2-amino-5-oxo-8-nonenoic acid ethyl ester

[0026]

[0027] In a 3L three-neck flask equipped with a spherical condenser and a dropping funnel, add magnesium chips (51g, 2.09mol) and a small amount of iodine particles, and heat under a nitrogen stream to drive away the humid air. After 10 minutes, the system is sealed and protected by N2. Then inject anhydrous tetrahydrofuran solution (1.5L) of 1-butyl bromide (177g, 1.31mol) in the dropping funnel, and add 100mL solution at a time, after the reaction triggers, slowly add again, keep the reaction temperature at 60- between 70°C. After the dropwise addition, wait for the temperature of the reaction solution to drop to room temperature, and heat it with a hot air blower for half an hour to make the reaction fully. A solution of (S)-N-tert-butoxycarbonyl-pyroglutamic acid ethyl ester (320g, 1.24mol) i...

Embodiment 2

[0035] Synthesis of (R)-N-tert-butoxycarbonyl-2-amino-8-nonenoic acid

[0036] Step 1: Synthesis of (R)-N-tert-butoxycarbonyl-2-amino-5-oxo-8-nonenoic acid ethyl ester

[0037]

[0038] In a 3L three-neck flask equipped with a spherical condenser and a dropping funnel, add magnesium chips (3.6g, 0.15mol) and a small amount of iodine particles, heat under a nitrogen stream to drive off the humid air, and after 10 minutes, seal the system and protect it with nitrogen. , then inject anhydrous tetrahydrofuran solution (150mL) of 1-butyl bromide (13.5g, 1.00mol) into the dropping funnel, and add 100mL solution at a time, after the reaction triggers, slowly add it again, keeping the reaction temperature at 60 Between -70°C. After the dropwise addition, wait for the temperature of the reaction solution to drop to room temperature, and heat it with a hot air blower for half an hour to make the reaction fully. A solution of (R)-N-tert-butoxycarbonyl-pyroglutamic acid ethyl ester (25...

Embodiment 3

[0043] Synthesis of (S)-N-tert-butoxycarbonyl-2-amino-8-nonenoic acid ethyl ester

[0044]

[0045] Tosylhydrazide (20.5 g, 0.11 mol) was added to ethyl (S)-N-tert-butoxycarbonyl-2-amino-5-oxo-8-nonenoate (31.3 g, 0.10 mol) in acetic acid ( 400 mL) solution, stirred at room temperature for one hour, then added sodium borohydride (19 g, 0.50 mol) in batches, and continued to stir for 12-24 hours after the addition was complete. After the reaction was detected by TLC, it was quenched by adding water and extracted with ethyl acetate. The organic phases were combined, washed successively with saturated aqueous sodium bicarbonate solution and saturated saline solution, filtered, the filtrate was concentrated under reduced pressure, and the crude product was purified by column chromatography to obtain (S)-N-tert-butoxycarbonyl-2-amino-8-nonene Acetate ethyl ester (16.8 g, 56% yield). MS(E / Z): 300(M+H + ).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

This invention relates to a method for preparing 2-amino-8-nonenoic acid, especially optically active 2-amino-8-nonenoic acid. The method overcomes the problems of long synthesis route, low yield and expensive chiral catalyst or resolution reagent faced by the present method. The method comprises: attacking chiral pyroglutamate containing protecting groups with Grignard reagent of crotyl bromide to obtain chiral 2-amino-5-oxy-8- nonanoate, reducing to remove carbonyl and obtain chiral or racemized 2-amino-8-nonanoate, and hydrolyzing to obtain optically active 2-amino-8-nonenoic acid. The method in this invention has such advantages as simple route, reasonable process, and high yield, and is suitable for mass production.

Description

Technical field: [0001] The present invention relates to a practical synthesis of optically active 2-amino-8-nonenoic acid with terminal double bonds. Background technique: [0002] HCV may cause cirrhosis and liver cancer. Currently, about 170 million people around the world are infected with the virus, but there is no relevant preventive vaccine. Treatment is usually a combination of interferon and antiviral drugs, but can cause patients to develop symptoms such as colds, muscle pain and anemia. Due to the rapid spread of hepatitis C disease and the huge unsatisfied demand for hepatitis C treatment in the medical field, the current anti-hepatitis C drugs under research in the research and development lines of major pharmaceutical companies constitute a "dazzling" landscape. Boehringer Ingelheim's research product BILN2061 is the first high-profile product in this regard, and it only needs 2 days of treatment to destroy the virus. However, because the initial experiments...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C229/30C07C227/18
CPCY02P20/55
Inventor 董华缪伟张治柳董径超施一峰马汝建陈曙辉李革
Owner 上海药明康德新药开发有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com